Mereo BioPharma and Ultragenyx advance Phase 3 Orbit study for osteogenesis imperfecta

Related
In one of Biden’s first speeches since his cancer diagnosis,...
23 minutes ago
0
Hudbay Minerals suspends Snow Lake operations due to wildfir...
49 minutes ago
0
Merck Animal Health gets FDA nod for Bravecto Quantum
2 hours ago
0
Century Therapeutics files $200M mixed shelf offering
2 hours ago
0
Alpine Banks of Colorado declares $0.21 dividend
2 hours ago
0
AptarGroup declares $0.45 dividend
2 hours ago
0
Avient declares $0.27 dividend
2 hours ago
1
Federal Agricultural Mortgage announces CFO resignation
2 hours ago
0
abrdn World Healthcare Fund declares $0.1167 dividend
2 hours ago
1